Error: Could not add to watchlist. X

UBS Lux Equity Fund - Biotech USD

+ Watchlist
UIOLU:LX
Luxembourg
659.01
USD
0.00
0.00%
As of 03:05:45 ET on 06/29/2015.
Volume
0
Previous Close
659.01
52Wk Range
419.17 - 684.75
1 Yr Return
46.45%
NAV (on -)
-
Total Assets (b USD) (on 06/29/2015)
1.700
Inception Date
-
Premium/Discount
-
Average 52-Week Premium
-
Fund Managers
NATHALIE LOTSCHER PETRUS / SARAH COTTER
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Expense Ratio
2.08%
3 Mo Return
4.46%
3 Yr Return
41.49%
5 Yr Return
31.74%
Top Fund Holdings
Name Position Value % of Fund
Biogen Inc 420.73 k 157.32 m 9.49
Gilead Sciences Inc 1.52 m 153.18 m 9.24
Amgen Inc 921.93 k 145.58 m 8.79
Celgene Corp 1.08 m 116.33 m 7.02
BioMarin Pharmaceutical Inc 863.61 k 96.77 m 5.84
Vertex Pharmaceuticals Inc 670.02 k 82.60 m 4.98
Regeneron Pharmaceuticals Inc 176.64 k 80.80 m 4.88
Alexion Pharmaceuticals Inc 447.60 k 75.75 m 4.57
Incyte Corp 683.40 k 66.40 m 4.01
Medivation Inc 522.80 k 63.12 m 3.81
Profile
UBS Lux Equity Fund - Biotech USD is an open-end investment fund incorporated in Luxembourg. The Fund's objective is medium- to long-term capital growth. The Fund invests globally in equities of companies engaged in research, product development, product manufacturing and distribution in the biotechnology sector.
ADDRESS
UBS Equity Fund Management Company
33A avenue J.F. Kennedy
L-1855 Luxembourg
Luxembourg
PHONE
352-44-10-10-1 Tel